Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. A three-drug cocktail known as ...
Please provide your email address to receive an email when new articles are posted on . Over a 16-year period, those with cystic fibrosis vs. sickle cell disease had a larger improvement in mean age ...
Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care. The research team, led by Murdoch Children's ...
The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A cell-penetrating nanobody restores function in cystic fibrosis—and points to a new class ...
Cystic fibrosis, or CF, is a lifelong genetic condition that affects how the body produces mucus, sweat, and digestive fluids. More than 100,000 people across 94 countries have been diagnosed with ...
BOSTON--(BUSINESS WIRE)--Porosome Therapeutics, Inc. (Porosome Therapeutics) today announced the publishing of a study that brings promise for a cure to cystic fibrosis (CF). The preprint highlights ...
When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to imagine what is happening inside their own bodies. "I tell them to picture ...
A fundamental challenge for cystic fibrosis (CF) gene therapy is ensuring sufficient transduction of airway epithelial cells to achieve therapeutic correction. Gene editing is a method to permanently ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly ...
Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care.